Teleflex (TFX) Competitors

IDEXX Laboratories (NASDAQ:IDXX) and Teleflex (NYSE:TFX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, community ranking, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Do insiders and institutionals have more ownership in IDXX or TFX?

87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 2.1% of IDEXX Laboratories shares are held by company insiders. Comparatively, 1.4% of Teleflex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community favor IDXX or TFX?

IDEXX Laboratories received 7 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 72.24% of users gave IDEXX Laboratories an outperform vote while only 59.28% of users gave Teleflex an outperform vote.

Company	Underperform	Outperform
IDEXX Laboratories	Outperform Votes 531 72.24%	Underperform Votes 204 27.76%
Teleflex	Outperform Votes 524 59.28%	Underperform Votes 360 40.72%

Which has higher valuation and earnings, IDXX or TFX?

IDEXX Laboratories has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$3.84B	8.92	$845.04M	$10.37	40.37
Teleflex	$3.03B	2.88	$356.33M	$5.03	37.27

Does the media prefer IDXX or TFX?

In the previous week, IDEXX Laboratories had 6 more articles in the media than Teleflex. MarketBeat recorded 17 mentions for IDEXX Laboratories and 11 mentions for Teleflex. IDEXX Laboratories' average media sentiment score of 1.30 beat Teleflex's score of 0.67 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	13 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Which has more volatility and risk, IDXX or TFX?

IDEXX Laboratories has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500.

Is IDXX or TFX more profitable?

IDEXX Laboratories has a net margin of 22.53% compared to Teleflex's net margin of 7.85%. IDEXX Laboratories' return on equity of 55.42% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	22.53%	55.42%	25.90%
Teleflex	7.85%	14.19%	8.53%

Do analysts recommend IDXX or TFX?

IDEXX Laboratories currently has a consensus target price of $552.38, indicating a potential upside of 31.95%. Teleflex has a consensus target price of $259.25, indicating a potential upside of 38.29%. Given Teleflex's higher probable upside, analysts clearly believe Teleflex is more favorable than IDEXX Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Teleflex	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

IDEXX Laboratories beats Teleflex on 16 of the 18 factors compared between the two stocks.